jandjsign
CEO Joaquin Duato told investors on Wednesday’s earnings call that the provisions of the law have “enabled” Johnson & Johnson’s commitment to invest $55 billion in the U.S.

Be Sure To Read

piramalbldg
Peter DeYoung, CEO of Piramal Global Pharma, says the geopolitical situation and trend toward onshoring “happens to be synergistic” with its investment in the United States.
labspace
A new survey from Unispace Life Sciences finds 57% of senior executives see the adoption of intelligent systems as critical to the next generation of laboratory environments.
pillsunderglass
Out of 202 Complete Response Letters issued between 2020 and 2024, 150 involved quality/manufacturing issues, according to the regulator’s newly released documents.
hikmagroundbreaking
Generics, which make up approximately 90% of prescription volume in the U.S., are produced primarily in India as Hikma looks to onshore production of these critical drugs.
trumppic
The tariffs on pharmaceuticals would have a grace period of up to a year and a half to give drugmakers the opportunity to move their manufacturing operations to the U.S.
ezfillsyringesproduction2
After touring the Fishers facility, William Blair analysts say demand for syringes is “healthy and robust” with a sequential utilization ramp-up expected in coming quarters.

Exclusives

Pharma events calendar

Keep track of in-person industry events.


Articles

The latest content from industry thought leaders.


Editors' (re)View

Weekly takes on things going on in the pharma world.

shutterstock_479766829
Unlock the full potential of your GMP assets. Discover how life sciences organizations can optimize reliability, compliance, and performance with a data-driven approach to Asset...
prgreenquadrant2025verdantixthumbnaillinkedin
Successful AI-enabled operations depend on a solid industrial data strategy. Get there faster with these vendors.
pressreleasebenchmarkreportingfullhd
Confident you're using the right language model for your industrial application? See how they stack up in this unique report.
pressreleasecognitereleasefullhd
Three of Cognite's chemical, refining, and energy customers take center stage in this product tour video that showcases why and how they are transforming their operations.
lpgenerativeaiguidethumbnailwebfullhd_1
Are you making quick-enough progress on your industrial Gen AI journey? Learn what it actually takes to trust, deliver, and scale across operational use cases.
featuredimage
Optimize safety, efficiency, and compliance in biopharma fluid handling with this essential guide to managing single-use bioprocess bags. Learn how modular, ergonomic, and contamination...

With a focus on CGT manufacturing, BioForge will be operational by 2027.
Building on its manufacturing legacy, Pittsburgh is now headed in a new direction — from steel to science

shutterstock_2079390133
The future of non-clinical research may depend on integrating VCGs for a more humane and efficient approach.
A look at consequential drug approvals and rejections from this year
Michael Annino/Shutterstock AI
With key players entering the ring and many clinical trials underway, the molecular glue garden is bound to bloom soon
A first-of-its-kind study of isotopic values of paired reactants and products offers a prospective new method of process understanding

shutterstock_2467268685
Adhering to a tried-and-true set of best practices during the PPQ stage can prevent a drug approval from stalling out on the final lap.

Michael Annino | Shutterstock-AI
pm2409_hero854x480_2
Pharmacologic approaches to treating aging are edging closer to maturity
Michael Annino/Shutterstock AI
pm2409_hero854x480_2coverstory
New treatments offer the promise of tackling age-related disease multimorbidity
Michael Annino/Shutterstock AI
pm2409_hero854x480_coverstory
Novel therapeutic approaches to aging are creating a healthspan market with staying power

Slideshows

A robust contamination control strategy isn't merely a guideline, it's a necessity
Microsoft Teams Image (7)
Quick answers to all your pharma manufacturing questions
Shutterstock 749369605
13 pharma scaries….and solutions that offer reprieve